| Application no. and date | 20722087.2 (espacenet) (Federated) (European Patent Register), 20200402 | | Patent/reg. no. and date | DK/EP 3946595, 20231115 | | Publication date | 20220209 | | Priority no. and date | US 201962828699 P, 20190403 | | EP pub. no. and date |
EP 3946595 20220209 | | Effective date | | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | | Applicant ref. no. | P83465DK01 | | Inventor | MELILLO, Vito, 50 Northern Avenue
Boston, Massachusetts 02210, US,
HADIDA RUAH, Sara Sabina, 50 Northern Avenue
Boston, Massachusetts 02210, US,
MCCARTNEY, Jason, 50 Northern Avenue
Boston, Massachusetts 02210, US,
MILLER, Mark Thomas, 50 Northern Avenue
Boston, Massachusetts 02210, US,
UY, Johnny, 50 Northern Avenue
Boston, Massachusetts 02210, US,
ZHOU, Jinglan, 50 Northern Avenue
Boston, Massachusetts 02210, US,
ISHIHARA, Yoshihiro, 50 Northern Avenue
Boston, Massachusetts 02210, US,
KRENITSKY, Paul, 50 Northern Avenue
Boston, Massachusetts 02210, US,
SILINA, Alina, 50 Northern Avenue
Boston, Massachusetts 02210, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61P 11/00 (2006.01) , C07D 239/69 (2006.01) , C07D 515/08 (2006.01) | | Title | MODULERINGSMIDLER AF CYSTISK FIBROSE TRANSMEMBRANKONDUKTANSREGULATOR | | Int. application no. | US2020026331 | | Int. publication no. | WO2020206080 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
